3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
12
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Mesothelioma
44
Mesothelioma, Malignant
42
Retinoblastoma
35
Solid Tumor
27
Lung Neoplasms
16
Hematopoietic and Lymphatic System Neoplasm
16
Pancreatic Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Unspecified Adult Solid Tumor, Protocol Specific
12
Solid Tumors
11
Solid Tumor, Adult
10
Ovarian Neoplasms
10
Neoplasms
10
Sarcoma
9
Melanoma
9
Carcinoma, Renal Cell
9
Thymus Neoplasms
8
Stomach Neoplasms
8
Esophageal Neoplasms
8
Breast Neoplasms
8
Small Cell Lung Carcinoma
7
Colonic Neoplasms
7
Urinary Bladder Neoplasms
6
Prostatic Neoplasms
6
Colorectal Neoplasms
6
Uterine Cervical Neoplasms
5
Thymoma
5
Neoplasms, Unknown Primary
5
Kidney Neoplasms
5
Cholangiocarcinoma
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Carcinoma, Pancreatic Ductal
×
Other solid neoplasm
×
Clear all
NCT05461430
2026-04-13
TraveraRTGx
Travera Inc
Completed
72 enrolled